-
公开(公告)号:US20110312088A1
公开(公告)日:2011-12-22
申请号:US13109957
申请日:2011-05-17
申请人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
发明人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
摘要翻译: 本发明尤其涉及CD19结合剂和使用这种CD19结合剂来治疗疾病的方法。
-
公开(公告)号:US07968687B2
公开(公告)日:2011-06-28
申请号:US12253895
申请日:2008-10-17
IPC分类号: C12P21/08
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention relates to CD 19 binding agents and methods of using such CD 19 binding agents for treating disease.
摘要翻译: 本发明涉及CD19结合剂和使用这种CD19结合剂治疗疾病的方法。
-
公开(公告)号:US09073993B2
公开(公告)日:2015-07-07
申请号:US13530074
申请日:2012-06-21
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
摘要翻译: 本发明尤其涉及CD19结合剂和使用这种CD19结合剂来治疗疾病的方法。
-
公开(公告)号:US20090136526A1
公开(公告)日:2009-05-28
申请号:US12253895
申请日:2008-10-17
申请人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans-Peter Gerber , Leigh Francisco
发明人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans-Peter Gerber , Leigh Francisco
IPC分类号: A61K39/395 , C07K16/18 , C12N15/11
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
摘要翻译: 本发明尤其涉及CD19结合剂和使用这种CD19结合剂来治疗疾病的方法。
-
公开(公告)号:US20120294853A1
公开(公告)日:2012-11-22
申请号:US13530074
申请日:2012-06-21
申请人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
发明人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
IPC分类号: A61K39/395 , A61P35/02 , A61P35/00
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention, inter alia, relates to CD19 binding agents and methods of using such CD19 binding agents for treating disease.
摘要翻译: 本发明尤其涉及CD19结合剂和使用这种CD19结合剂来治疗疾病的方法。
-
公开(公告)号:US08242252B2
公开(公告)日:2012-08-14
申请号:US13109957
申请日:2011-05-17
申请人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
发明人: Charlotte McDonagh , Charles G. Cerveny , Dennis Benjamin , Paul Carter , Hans Peter Gerber , Leigh Francisco
IPC分类号: C07H21/04
CPC分类号: A61K47/6803 , A61K38/05 , A61K47/6811 , A61K47/6849 , A61K47/6867 , A61K2039/505 , C07K16/2803 , C07K16/3061 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/77 , Y02A50/401 , Y02A50/41 , Y02A50/412 , Y02A50/414 , Y02A50/423
摘要: This invention relates to CD 19 binding agents and methods of using such CD 19 binding agents for treating disease.
摘要翻译: 本发明涉及CD19结合剂和使用这种CD19结合剂治疗疾病的方法。
-
公开(公告)号:US20100260786A1
公开(公告)日:2010-10-14
申请号:US12762843
申请日:2010-04-19
IPC分类号: A61K39/395 , A61P35/00
CPC分类号: C07K5/06052 , A61K47/6809 , A61K47/6811
摘要: Methods of treating a refractory or drug resistant cancer, cell proliferative disorder and tumor cells are provided.
摘要翻译: 提供了治疗难治性或耐药性癌症,细胞增殖性病症和肿瘤细胞的方法。
-
8.CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF 审中-公开
标题翻译: CD37免疫组织化学与双功能化学疗法公开(公告)号:US20140086903A1
公开(公告)日:2014-03-27
申请号:US13844269
申请日:2013-03-15
申请人: Philip TAN , Charles G. Cerveny , Sandy A. Simon , Anne Nilsson , William Brady , Peter A. Thompson , Cecile Morales
发明人: Philip TAN , Charles G. Cerveny , Sandy A. Simon , Anne Nilsson , William Brady , Peter A. Thompson , Cecile Morales
IPC分类号: A61K39/395 , A61K31/4184 , A61K38/16
CPC分类号: A61K39/39541 , A61K31/4184 , A61K38/16 , A61K39/39558 , A61K2039/505 , C07K16/2896 , C07K16/3061 , C07K16/461 , C07K2317/24 , C07K2317/50
摘要: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
摘要翻译: 本公开内容提供人源化抗CD37小模块化免疫药物(SMIP)分子,以及CD37-特异性结合分子(例如抗CD37SMIP蛋白或抗体)与双功能化学治疗剂(例如苯达莫司汀)的协同组合疗法,其可以 同时或相继施用,用于治疗或预防B细胞相关的自身免疫性,炎症性或过度增殖性疾病。
-
9.CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF 有权
标题翻译: CD37免疫组织化学与双功能化学疗法公开(公告)号:US20110171208A1
公开(公告)日:2011-07-14
申请号:US12678857
申请日:2009-04-11
申请人: Philip Tan , Sandy Alexander Simon , Charles G. Cerveny , Christy Anne Nilsson , William Brady , Jeffrey A. Ledbetter , Martha Susan Hayden-Ledbetter , Peter Armstrong Thompson , Cecile Morales
发明人: Philip Tan , Sandy Alexander Simon , Charles G. Cerveny , Christy Anne Nilsson , William Brady , Jeffrey A. Ledbetter , Martha Susan Hayden-Ledbetter , Peter Armstrong Thompson , Cecile Morales
IPC分类号: A61K39/395 , C07K16/00 , A61P35/00
CPC分类号: A61K39/39541 , A61K31/4184 , A61K38/16 , A61K39/39558 , A61K2039/505 , C07K16/2896 , C07K16/3061 , C07K16/461 , C07K2317/24 , C07K2317/50
摘要: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.
摘要翻译: 本公开内容提供人源化抗CD37小模块化免疫药物(SMIP)分子,以及CD37-特异性结合分子(例如抗CD37SMIP蛋白或抗体)与双功能化学治疗剂(例如苯达莫司汀)的协同组合疗法,其可以 同时或顺序施用,用于治疗或预防B细胞相关的自身免疫性,炎症性或过度增殖性疾病。
-
10.CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF 有权
标题翻译: CD37免疫组织化学与双功能化学疗法公开(公告)号:US20090274692A1
公开(公告)日:2009-11-05
申请号:US12422780
申请日:2009-04-13
申请人: Phillip Tan , Sandy A. Simon , Charles G. Cerveny , Christy Anne Nilsson , William Brady , Jeffrey A. Ledbetter , Martha S. Hayden-Ledbetter , Peter A. Thompson , Cecile Morales
发明人: Phillip Tan , Sandy A. Simon , Charles G. Cerveny , Christy Anne Nilsson , William Brady , Jeffrey A. Ledbetter , Martha S. Hayden-Ledbetter , Peter A. Thompson , Cecile Morales
CPC分类号: A61K39/39541 , A61K31/4184 , A61K38/16 , A61K39/39558 , A61K2039/505 , C07K16/2896 , C07K16/3061 , C07K16/461 , C07K2317/24 , C07K2317/50
摘要: The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases.
摘要翻译: 本公开内容提供人源化抗CD37小模块化免疫药物(SMIP)分子,以及CD37-特异性结合分子(例如抗CD37SMIP蛋白或抗体)与双功能化学治疗剂(例如苯达莫司汀)的协同组合疗法,其可以 同时或相继施用,用于治疗或预防B细胞相关的自身免疫性,炎症性或过度增殖性疾病。
-
-
-
-
-
-
-
-
-